Lexicon grants license to GlaxoSmithKline

GlaxoSmithKline (GSK; LSE:GSK) received a non-exclusive sublicense to LEXG's gene targeting technologies, for use in the pharma company's internal research programs. LEXG will receive an upfront techn...